N-(1-benzylpiperidin-4-yl)-4-carbamothioylbenzamide

ID: ALA5205647

PubChem CID: 113221222

Max Phase: Preclinical

Molecular Formula: C20H23N3OS

Molecular Weight: 353.49

Names and Identifiers

Canonical SMILES:  NC(=S)c1ccc(C(=O)NC2CCN(Cc3ccccc3)CC2)cc1

Standard InChI:  InChI=1S/C20H23N3OS/c21-19(25)16-6-8-17(9-7-16)20(24)22-18-10-12-23(13-11-18)14-15-4-2-1-3-5-15/h1-9,18H,10-14H2,(H2,21,25)(H,22,24)

Standard InChI Key:  MDRXXGMJEJFONZ-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 25 27  0  0  0  0  0  0  0  0999 V2000
   -4.6425    1.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9279    1.8558    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2160    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.2160    0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -3.9261    0.2070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -4.6425    0.6151    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5014    1.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7867    1.4440    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0721    1.8565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3575    1.4440    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3575    0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0721    0.2062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7867    0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3570    0.2062    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.0717    0.6188    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7864    0.2062    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0717    1.4440    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.5011    0.6186    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2132    0.2066    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2132   -0.6187    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5029   -1.0307    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7864   -0.6224    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9279   -1.0313    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6425   -0.6187    0.0000 S   0  0  0  0  0  0  0  0  0  0  0  0
    3.9279   -1.8565    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  2  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  3  7  1  0
  7  8  1  0
  9  8  1  0
 10  9  1  0
 11 10  1  0
 12 11  1  0
 13 12  1  0
  8 13  1  0
 11 14  1  0
 14 15  1  0
 15 16  1  0
 15 17  2  0
 18 16  2  0
 19 18  1  0
 20 19  2  0
 21 20  1  0
 22 21  2  0
 16 22  1  0
 20 23  1  0
 23 24  2  0
 23 25  1  0
M  END

Alternative Forms

1. Parent:

   

   ALA5205647

   N-(1-benzylpiperidin-4-yl)-4-carbamothioylbenzamide

Molecule Features

Natural Product: No

Oral: No

Chemical Probe: No

Parenteral: No

Molecule Type:

Topical: No

First In Class: No

Black Box: No

Chirality: No

Availability: No

Prodrug: No

Calculated Properties

Molecular Weight: 353.49

Molecular Weight (Monoisotopic): 353.1562

AlogP: 2.72

#Rotatable Bonds: 5

Polar Surface Area: 58.36

Molecular Species: BASE

HBA: 3

HBD: 2

#RO5 Violations: ┄

HBA (Lipinski): 4

HBD (Lipinski): 3

#RO5 Violations (Lipinski): ┄

CX Acidic pKa: 12.04

CX Basic pKa: 8.52

CX LogP: 2.54

CX LogD: 1.39

Aromatic Rings: 2

Heavy Atoms: 25

QED Weighted: 0.81

Np Likeness Score: -1.39

References

1. Dichiara M, Artacho-Cordón A, Turnaturi R, Santos-Caballero M, González-Cano R, Pasquinucci L, Barbaraci C, Rodríguez-Gómez I, Gómez-Guzmán M, Marrazzo A, Cobos EJ, Amata E..  (2022)  Dual Sigma-1 receptor antagonists and hydrogen sulfide-releasing compounds for pain treatment: Design, synthesis, and pharmacological evaluation.,  230  [PMID:35016113] [10.1016/j.ejmech.2021.114091]

Source

Source(1):

• Scientific Literature